TWIST BIOSCIENCE CORP (TWST)
NASDAQ • Healthcare
$116.1
-$8.31 (-6.7%)
Market open
Last close at August 18, 2026 at 20:00 UTC
Fundamentals Charts
About TWIST BIOSCIENCE CORP
Name
TWIST BIOSCIENCE CORP
CEO
Emily Marine Leproust
Website
Industry
Healthcare
Year Founded
2013
Employees
979
Twist Bioscience Corporation trades on the NASDAQ as TWST and operates in healthcare, focused on research tools and molecular products for diagnostics and drug discovery. The company uses a DNA synthesis platform that writes artificial DNA directly onto silicon chips, and it generated $376.6 million of revenue in FY2025.
Fundamentals & Financials
Revenue (TTM)
$431.7M
Net Income (TTM)
-$136.7M
EPS (TTM)
-$2.22
ROA (TTM)
-20.33%
Current Ratio
2.67
TTM is calculated as the sum of the four most recently completed quarters. This is a standard approach when monthly or real-time data is not available.
Income Statement
Balance Sheet
Financial Highlights
Dividends History
Split History
Earnings Calendar
Stay Ahead of the Market
Get premium market insights delivered directly to your inbox.
Quote Summary
Previous CloseDay Range$116.1$115.28 - $123.3
52 Week RangeAvg. Volume$23.3 - $126.41.5M
Market Cap$8.5B
Peers & Related Assets
EWTXEDGEWISE THERAPEUTICS INC
$44.11+0.2%
GRDNGUARDIAN PHARMACY SERVICES INC CLA
$38.28+0.7%
QDELQUIDELORTHO CORP
$13.43-7.9%
QUREuniQure N.V.
GPCRStructure Therapeutics Inc.
VRDNVIRIDIAN THERAPEUTICS ORS INC
MESOMesoblast Limited
CLOVCLOVER HEALTH INVESTMENTS CORP CLA
PRCTPROCEPT BIOROBOTICS CORP
BGMBGM Group Ltd.